Facebook
X
LinkedIn
ForwardEarly Recognition and Intervention in Cancer Cachexia - Webinar Part 1
In a recent webinar, Professors Aminah Jatoi, Jeffrey Crawford, and Rony Dev delved into the multifaceted nature of cancer cachexia, examining its definition, underlying pathophysiology, and profound impact on patients' quality of life. The session underscored the critical importance of early diagnosis and timely intervention, highlighting a multidisciplinary approach that includes nutritional support, physical activity, and pharmacologic therapies.
Target Audience
Healthcare Professionals
Learning Objectives
- Gain a comprehensive understanding of the multifactorial nature of cancer cachexia, including its prevalence, clinical impact, and disease burden.
- Understand the clinical symptoms, diagnostic criteria, and staging of cancer cachexia, and emphasize the importance of early recognition
- Develop skills to implement a multi-modal approach to managing cancer cachexia.
- Create effective communication strategies to inform patients and their care providers about cancer cachexia.
This activity is supported by an educational grant from Pfizer.
Course summary
Aminah Jatoi, M.D
Betty J. Foust, MD and Parents' Professor of Oncology, Mayo Clinic, Rochester, Minnesota
Aminah Jatoi, M.D discloses the following: DSM/Advisory Board Fees: Pfizer, honorarium to institution
Dr. Rony Dev
Associate Professor, Department of Palliative Care and Rehabilitation Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
Professor Jeffrey Crawford
George Barth Geller Professor Emeritus for Research in Cancer, Department of Medicine, Duke University Medical Center
Accreditation for this activity has expired.